FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4322750162> ?p ?o ?g. }

• W4322750162 endingPage "393" @default.
• W4322750162 startingPage "382" @default.
• W4322750162 abstract "COVID-19 is a disease that caused a prolonged pandemic in many countries caused by the SARS-CoV-2 virus. This study aims to identify the antiviral potential of secondary metabolites in Gorontalo traditional medicinal plants, which are believed to have the ability to inhibit the main protease protein of this virus. The methods used in this research were molecular docking and molecular dynamic. The main protease proteins for SARS-CoV-2 used based on the homology modeling results were 3V3M and 7TE0. The results of the active compounds in the paxlovid drug were also compared to obtain accurate data comparisons. The validation of the docking method on the 3V3M protein using the natural ligand 0EN revealed an RMSD of 0.75 Å. The RMSD value for validating the 7TE0 protein and natural ligand 4WI was 1.65 Å. The best molecular docking results were obtained using physalin F with a binding affinity of −10.3 kcal/mol for the 3V3M protein and physalin J with a binding affinity of −8.9 kcal/mol for the 7TE0 protein. The outcomes of the molecular dynamic method on the best complexes were determined by examining the value of changes in system energy, changes in system temperature, changes in system pressure, RMSD, RMSF, and bond-free energy (ΔG) of the complex. The standard 0EN ligand had a ΔG of −26.53 kcal/mol, while the standard 4WI ligand had a ΔG of −47.16 kcal/mol. The ΔG of the 3V3M-physalin F and 3V3M-physalin J complexes were respectively −28.22 kcal/mol and −26.62 kcal/mol. The ΔG of the 7TE0-Vitexin 2”-O-gallate and 7TE0-physalin J complexes were found to be −28.08 kcal/mol and −26.62 kcal/mol, respectively. The ΔG produced in paxlovid with complexes 3V3M and 7TE0 was −19.38 kcal/mol and −25.44 kcal/mol, respectively. Physalin F, physalin J, and Vitexin 2”-O-gallate have great potential to become SARS-CoV-2 inhibitor agents. However, in terms of structural stability and binding-active residues, these three compounds do not outperform the active substance in paxlovid." @default.
• W4322750162 created "2023-03-03" @default.
• W4322750162 creator A5040140125 @default.
• W4322750162 creator A5044171056 @default.
• W4322750162 creator A5056982793 @default.
• W4322750162 creator A5057598692 @default.
• W4322750162 creator A5058936889 @default.
• W4322750162 creator A5077248698 @default.
• W4322750162 date "2022-12-24" @default.
• W4322750162 modified "2023-10-18" @default.
• W4322750162 title "Screening of Secondary Metabolite Compounds of Gorontalo Traditional Medicinal Plants Using the In Silico Method as a Candidate for SARS-CoV-2 Antiviral" @default.
• W4322750162 cites W1031578623 @default.
• W4322750162 cites W2019874994 @default.
• W4322750162 cites W2031168104 @default.
• W4322750162 cites W2056232928 @default.
• W4322750162 cites W2105668062 @default.
• W4322750162 cites W2134967712 @default.
• W4322750162 cites W2161605421 @default.
• W4322750162 cites W2165471888 @default.
• W4322750162 cites W2169678694 @default.
• W4322750162 cites W3011701533 @default.
• W4322750162 cites W3012189167 @default.
• W4322750162 cites W3040142206 @default.
• W4322750162 cites W3092301334 @default.
• W4322750162 cites W3093085773 @default.
• W4322750162 cites W3111988956 @default.
• W4322750162 cites W3113418104 @default.
• W4322750162 cites W3136190261 @default.
• W4322750162 cites W3141067875 @default.
• W4322750162 cites W3149377625 @default.
• W4322750162 cites W3162940108 @default.
• W4322750162 cites W3212262184 @default.
• W4322750162 cites W4210736465 @default.
• W4322750162 cites W4221100330 @default.
• W4322750162 cites W4255351124 @default.
• W4322750162 doi "https://doi.org/10.14710/jksa.25.10.382-393" @default.
• W4322750162 hasPublicationYear "2022" @default.
• W4322750162 type Work @default.
• W4322750162 citedByCount "0" @default.
• W4322750162 crossrefType "journal-article" @default.
• W4322750162 hasAuthorship W4322750162A5040140125 @default.
• W4322750162 hasAuthorship W4322750162A5044171056 @default.
• W4322750162 hasAuthorship W4322750162A5056982793 @default.
• W4322750162 hasAuthorship W4322750162A5057598692 @default.
• W4322750162 hasAuthorship W4322750162A5058936889 @default.
• W4322750162 hasAuthorship W4322750162A5077248698 @default.
• W4322750162 hasBestOaLocation W43227501621 @default.
• W4322750162 hasConcept C104317684 @default.
• W4322750162 hasConcept C116569031 @default.
• W4322750162 hasConcept C147597530 @default.
• W4322750162 hasConcept C159110408 @default.
• W4322750162 hasConcept C170493617 @default.
• W4322750162 hasConcept C181199279 @default.
• W4322750162 hasConcept C185592680 @default.
• W4322750162 hasConcept C2775905019 @default.
• W4322750162 hasConcept C2776714187 @default.
• W4322750162 hasConcept C2780430158 @default.
• W4322750162 hasConcept C41685203 @default.
• W4322750162 hasConcept C55493867 @default.
• W4322750162 hasConcept C59593255 @default.
• W4322750162 hasConcept C70721500 @default.
• W4322750162 hasConcept C71240020 @default.
• W4322750162 hasConcept C71924100 @default.
• W4322750162 hasConcept C86803240 @default.
• W4322750162 hasConceptScore W4322750162C104317684 @default.
• W4322750162 hasConceptScore W4322750162C116569031 @default.
• W4322750162 hasConceptScore W4322750162C147597530 @default.
• W4322750162 hasConceptScore W4322750162C159110408 @default.
• W4322750162 hasConceptScore W4322750162C170493617 @default.
• W4322750162 hasConceptScore W4322750162C181199279 @default.
• W4322750162 hasConceptScore W4322750162C185592680 @default.
• W4322750162 hasConceptScore W4322750162C2775905019 @default.
• W4322750162 hasConceptScore W4322750162C2776714187 @default.
• W4322750162 hasConceptScore W4322750162C2780430158 @default.
• W4322750162 hasConceptScore W4322750162C41685203 @default.
• W4322750162 hasConceptScore W4322750162C55493867 @default.
• W4322750162 hasConceptScore W4322750162C59593255 @default.
• W4322750162 hasConceptScore W4322750162C70721500 @default.
• W4322750162 hasConceptScore W4322750162C71240020 @default.
• W4322750162 hasConceptScore W4322750162C71924100 @default.
• W4322750162 hasConceptScore W4322750162C86803240 @default.
• W4322750162 hasIssue "10" @default.
• W4322750162 hasLocation W43227501621 @default.
• W4322750162 hasOpenAccess W4322750162 @default.
• W4322750162 hasPrimaryLocation W43227501621 @default.
• W4322750162 hasRelatedWork W2029973510 @default.
• W4322750162 hasRelatedWork W2064956914 @default.
• W4322750162 hasRelatedWork W2092236356 @default.
• W4322750162 hasRelatedWork W2288137038 @default.
• W4322750162 hasRelatedWork W2392683545 @default.
• W4322750162 hasRelatedWork W2491451478 @default.
• W4322750162 hasRelatedWork W2740195147 @default.
• W4322750162 hasRelatedWork W3124243165 @default.
• W4322750162 hasRelatedWork W4289131259 @default.
• W4322750162 hasRelatedWork W4297909562 @default.
• W4322750162 hasVolume "25" @default.
• W4322750162 isParatext "false" @default.
• W4322750162 isRetracted "false" @default.

• next